Angelo de Claro was named acting director of the FDA Oncology Center of Excellence, following Richard Pazdur’s departure from that position—and the agency (The Cancer Letter, Dec. 5, 2025).
Harvey A. Risch, professor emeritus and senior research scientist at Yale School of Public Health, was named chair of the President’s Cancer Panel.
